Cita APA

Hirsh, V., Melosky, B., Goss, G., Morris, D., & Morzycki, W. (2012). A personalized approach to treatment: Use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada. Multimed Inc.

Chicago Style Citation

Hirsh, V., B. Melosky, G. Goss, D. Morris, i W. Morzycki. A Personalized Approach to Treatment: Use of Egfr Tyrosine Kinase Inhibitors for the Treatment of Non-small-cell Lung Cancer in Canada. Multimed Inc, 2012.

Cita MLA

Hirsh, V., et al. A Personalized Approach to Treatment: Use of Egfr Tyrosine Kinase Inhibitors for the Treatment of Non-small-cell Lung Cancer in Canada. Multimed Inc, 2012.